NCT01391962 2026-02-02
Sunitinib or Cediranib for Alveolar Soft Part Sarcoma
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
National Institutes of Health Clinical Center (CC)
The University of Texas Health Science Center at San Antonio
ProTechSure Scientific, Inc.
Amryt Pharma